List view / Grid view

Dr Daniel Ives (CEO of Shift Bioscience)

 

news

SB000: a safer path to anti-aging therapies

Shift Bioscience has announced new aging research, highlighting the discovery…

16 June 2025 | By

Shift Bioscience has announced new aging research, highlighting the discovery of SB000. This novel single-gene target reverses cellular aging without activating dangerous pluripotency pathways.